[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.206.168.65. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
March 1984

Treatment of Palmoplantar Pustulosis With Intralesional Triamcinolone Injections

Arch Dermatol. 1984;120(3):319-323. doi:10.1001/archderm.1984.01650390041008
Abstract

• Five patients with chronic intermittent palmoplantar pustulosis were treated with intralesional injections of 3.3 to 5.0 mg/mL of triamcinolone acetonide. Prompt clearing of symptoms and lesions ensued, lasting three to six months. Despite the discomfort experienced from the injections, patients preferred this treatment modality over others. Minor side effects included hypopigmentation, cutaneous atrophy, and, in one case, exacerbation of a latent dermatophyte infection.

(Arch Dermatol 1984;120:319-323)

×